Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,169 | -49,625 | -32,987 | -17,404 | -67,061 |
| Depreciation Amortization | -4,605 | -2,710 | -1,434 | -539 | -927 |
| Accounts payable and accrued liabilities | -1,378 | -535 | -530 | -729 | 150 |
| Other Working Capital | -3,082 | -6,007 | -3,068 | -2,118 | 2,012 |
| Other Operating Activity | 9,559 | 6,689 | 4,699 | 3,018 | 8,065 |
| Operating Cash Flow | $-70,675 | $-52,188 | $-33,320 | $-17,772 | $-57,761 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -53,348 | -46,983 | -2,375 | 13,941 | -4,993 |
| PPE Investments | -298 | -193 | -186 | -175 | -410 |
| Investing Cash Flow | $-53,646 | $-47,176 | $-2,561 | $13,766 | $-5,403 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40,000 | 27,500 | 27,500 | 20,000 | 4,050 |
| Common Stock Issued | 85,969 | 85,953 | 16,238 | 96 | 68,738 |
| Financing Cash Flow | $125,969 | $113,453 | $43,738 | $20,096 | $72,788 |
| Exchange Rate Effect | -18 | -152 | 30 | 19 | -25 |
| Beginning Cash Position | 33,269 | 33,269 | 33,269 | 33,269 | 23,670 |
| End Cash Position | 34,899 | 47,206 | 41,156 | 49,378 | 33,269 |
| Net Cash Flow | $1,630 | $13,937 | $7,887 | $16,109 | $9,599 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,675 | -52,188 | -33,320 | -17,772 | -57,761 |
| Capital Expenditure | -298 | -193 | -186 | -175 | -410 |
| Free Cash Flow | -70,973 | -52,381 | -33,506 | -17,947 | -58,171 |